Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-36143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 |
filingDate |
2013-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c6220676659fe081f15b2b56df02e89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee902f77cd3a601faf69652c3124dac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c02efa18e194ad8cfeee06784ec434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24feb21abea7203922e3b8287c7e202 |
publicationDate |
2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015140068-A1 |
titleOfInvention |
Immunogenic compositions and uses thereof |
abstract |
This invention generally relates to immunogenic compositions that comprise an HIV RNA component and a HIV polypeptide component. Immunogenic compositions that deliver antigenic epitopes in two different forms—a first epitope from human immunodeficiency virus (HIV), in RNA-coded form; and a second epitope from HIV, in polypeptide form—are effective in inducing immune response to HIV. The invention also relates to a kit comprising an HIV RNA-based priming composition and an HIV polypeptide-based boosting composition. The kit may be used for sequential administration of the priming and the boosting compositions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510973-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504421-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11639329-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016196471-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591619-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771747-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447566-B2 |
priorityDate |
2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |